Alivus Life
₹1,344
- Market Cap
- ₹16,055Cr.
- P/E Ratio
- 25.8
- P/B Ratio
- 4.96
- EPS (TTM)
- ₹52.09
- Div Yield
- 0.37%
- ROCE
- 23.8%
- ROE
- 17.9%
52W Low: ₹81952W High: ₹1,494
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 6.0% a year over three years.
- Debt is 0.02× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Alivus_Life — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 25.8P/E: 25.8 | P/B: 4.96Growth
ModestSales CAGR — 3Y: 6% · 1Y: 8%Profitability
High MarginROCE: 23.8% | ROE: 17.9%Key Metrics
Valuation
PEG Ratio 4.30
Price / Sales 6.20x
Price / FCF 62.0x
Book Value ₹271
Margins & returns
Operating Margin 32%
Net Margin 23.3%
Return on Assets 15.1%